Metabolic dysfunction‐associated steatotic liver disease, cardiometabolic risk factors, and cardiac manifestations in psoriasis: A cross‐sectional study of 255 patients
Cross-sectional analysis revealed associations between psoriasis, cardiac function, and metabolic risk factors, indicating obesity plays a significant role.
Key Points
Cardiac function was significantly affected in individuals with psoriasis, particularly those with diabetes.
92 participants (36.1%) had metabolic dysfunction–associated steatotic liver disease (MASLD), impacting heart function metrics.
Assessment utilized transthoracic echocardiography and transient elastography to evaluate cardiac structure and function.
Findings highlight the need for managing obesity and diabetes in psoriasis patients with cardiac concerns.